Seoul, South Korea · Founded 2018 · Privately Held (backing)
Developer of periodontal disease treatment drugs designed to offer periodontal disease treatment. MXBIO is based in Seoul, South Korea and was founded in 2018. It has raised $3.2 million.
Last price · $/share
—
Implied valuation
—
Total raised
$3.2M
Last round
—
Team — not yet on record
No current team members for MXBIO are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of MXBIO with a free account
·Watch MXBIO: the Monday email on marks, rounds and moves
